TAIPEI, Taiwan

He-Ru Chen

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: He-Ru Chen: Innovator in Liposomal Technology

Introduction

He-Ru Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of liposomal technology, particularly through his innovative methods for preparing liposomal compositions. His work has implications for various applications in pharmaceuticals and biomedicine.

Latest Patents

He-Ru Chen holds a patent for a "Liposomal composition containing mild acidic active agent." This patent describes a method for preparing a liposomal composition by contacting a liposome solution with a mild acidic agent for a limited time. The liposome solution includes a weak acid salt encapsulated within an aqueous interior space, separated from the aqueous medium by a membrane made of a lipid mixture. This method dramatically reduces the time required for encapsulating the agent to a desired amount at a predetermined ratio to lipids, even without elevating the temperature above ambient conditions. He holds 1 patent.

Career Highlights

Throughout his career, He-Ru Chen has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in liposomal formulations and their applications.

Collaborations

He-Ru Chen has collaborated with esteemed colleagues, including Ke-Ming Huang and Keelung Hong. These partnerships have contributed to the advancement of research and development in liposomal technologies.

Conclusion

He-Ru Chen's innovative work in liposomal technology showcases his commitment to advancing pharmaceutical science. His contributions continue to influence the field and pave the way for future developments in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…